 | |
| Company type | Private |
|---|---|
| Nasdaq: SNCE | |
| Industry | Clinical research |
| Founded | 2014 |
| Founders |
|
| Owner |
|
| Website | www |
Science 37 is an American clinical research company that specializes in decentralized clinical trials. In March 2024, the company was acquired by eMed, LLC. [1] [2]
Science 37 was founded in 2014 [3] by Noah Craft and Belinda Tan, working out of LA BioMed at Harbor-UCLA Medical Center. [4]
Their team developed the Network Oriented Research Assistant platform, also known as the NORA platform, which includes video chat, digital self-photography, data collection, and electronic consent. Together, these features were used to conduct “site-less” trials. [5]
The platform also aided researchers in finding and contacting potential participants, and scheduling trial participants for in-home activities like questionnaires, mobile nurse visits, [6] and door-step study medicine delivery. [7]
Science 37 received its initial round of funding in 2015, with a $6.5 million investment, co-led by Lux Capital and dRx Capital. [8] In 2016 the company's second round of financing resulted in $31 million in funding, and a 2017 round of financing resulted in $29 million. [9] [10] In March 2019, Science 37 secured $35 million in Series D funding; and announced a leadership transition with David Coman coming in as CEO in November 2019.
In August 2020 Science 37 closed an oversubscribed Series D $40 million funding round led by Lux Capital, Redmile Group and PPD, Inc. (other investors: Novartis, Amgen, Sanofi Ventures, GV, Glynn Capital, LifeSci Ventures and Mubadala Ventures). In May 2021, Science 37 announced that they are to become publicly listed via merger with LifeSci Acquisition II Corp.[ citation needed ]
In 2015 Science 37 began working with Genentech in the recruitment of trial participants. [11] In 2017 Science 37 then completed a site-less trial for AOBiome Therapeutics. This was the first “interventional, randomized, placebo-controlled trial” to be completed virtually. [5] That year Science 37 also began planning site-less trials for Sanofi [12] and Otsuka Pharmaceutical. [13]
In 2018 the company partnered with Novartis to plan several site-less clinical trials. Novartis also owns 10% of Science 37 from an early-stage investment in the company. [14] Science 37 was already in the process of conducting trials with Novartis in acne, cluster headaches, and fatty liver disease. [4]
Astex Pharmaceuticals ("Astex") is a biotechnology company focused on the discovery and development of drugs in oncology and diseases of the central nervous system. Astex was founded in 1999 by Sir Tom Blundell, Chris Abell & Harren Jhoti, and is located in Cambridge, England.
The European and Developing Countries Clinical Trials Partnership (EDCTP) is a partnership between the European Union (EU), Norway, Switzerland and developing countries and other donors, as well as the pharmaceutical industry, to enable clinical trials and the development of new medicines and vaccines against HIV/AIDS, tuberculosis, and malaria. The need for global action against these diseases in order to promote poverty reduction has been recognised by the United Nations, the G8, and the African Union, and the program envisioned the provision of €600 million for the period 2003–2007 in order to translate medical research results into clinical applications relevant to the needs of developing countries.
Khosla Ventures is an American venture capital firm founded by Vinod Khosla, focused on early-stage companies in the Internet, computing, mobile, financial services, agriculture, healthcare and clean technology sectors. Some of its most successful investments include Affirm, DoorDash, Square, Impossible Foods, Instacart, and OpenAI.
GV Management Company, L.L.C. is a venture capital investment arm of Alphabet Inc., founded by Bill Maris, that provides seed, venture, and growth stage funding to technology companies. Founded as Google Ventures in 2010, the firm has operated independently of Google, Alphabet's search and advertising division, since 2015. GV invests in startup companies in a variety of fields ranging from the Internet, software, and hardware to life science, healthcare, artificial intelligence, transportation, cyber security and agriculture. It has helped finance more than 300 companies that include Uber, Nest, Slack, and Flatiron Health.
Lux Capital is a venture capital firm based in New York City. It was founded in 2000, and focuses on investments in emerging technologies.
Medidata Solutions is an American technology company that develops and markets software as a service (SaaS) for clinical trials. These include protocol development, clinical site collaboration and management; randomization and trial supply management; capturing patient data through web forms, mobile health (mHealth) devices, laboratory reports, and imaging systems; quality monitor management; safety event capture; and monitoring and business analytics. Headquartered in New York City, Medidata has locations in China, Japan, Singapore, South Korea, the United Kingdom, and the United States.
Andreessen Horowitz is a private American venture capital firm, founded in 2009 by Marc Andreessen and Ben Horowitz. The company is headquartered in Menlo Park, California. As of April 2023, Andreessen Horowitz ranks first on the list of venture capital firms by assets under management, with $42 billion as of May 2024.
Osiris Therapeutics, Inc. was founded in March 1993 following the identification of mesenchymal stem cells (MSCs) by Dr. Arnold Caplan and colleagues at Case Western Reserve University in Cleveland Ohio. Dr. Caplan contributed a license to certain technology and joined Kevin Kimberlin, James S. Burns, a biotech venture capitalist, and Peter Friedli, a lead investor, to launch Osiris; Caplan and Burns had named the company after the Egyptian god of fertility, resurrection, and the afterlife. Early financing was provided by a number of entities, including Three Arch Bay Health Sciences Fund and Spencer Trask & Co. By 1994, the state of Maryland provided a loan and equity investment to lure the company from Ohio in 1995.
MicroVentures is an equity crowdfunding website that offers investments in early stage companies. It connects accredited investors with startups, businesses and services looking to raise funds or participate in select secondary market opportunities.
Purch Group, Inc. was a New York City-based digital media company. Originally established in 2003 as TechMedia Network, Inc., it was positioned as a "portfolio of brands and products focused on purchasing decisions"—consisting primarily of websites focusing on reviews of consumer electronics, positioned to marketers as outlets to "directly engage with buyers in the right place, at the right time".
HealthCap is a specialized provider of venture capital within life sciences. HealthCap invests in innovative companies with focus on therapeutics. As of 2023, HealthCap has invested in over 125 companies since inception and completed initial public offerings of more than 45 companies. HealthCap has offices in Stockholm and Lausanne.
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list.
CapitalG Management Company LLC is the independent growth fund under Alphabet Inc. Founded in 2013, it focuses on larger, growth-stage technology companies, and invests for profit rather than strategically for Google. In addition to capital investment, CapitalG's approach includes giving portfolio companies access to Google's people, knowledge, and culture to support the companies' growth and offer them guidance.
uSens, Inc. is a Silicon Valley startup founded in 2014 in San Jose, California. The company builds interactive computer-vision tracking solutions. The uSens team has extensive experience in artificial intelligence (AI), computer vision, 3D Human–computer interaction (HCI) technology and augmented reality and virtual reality. uSens has been applying computer vision and AI technologies in AR/VR, Automotive and smartphones.
Nomad Health is an online marketplace that directly connects physicians, nurses, and medical facilities for healthcare jobs, without the involvement of third party employment agencies. Nomad Health is based in New York City.
Almaz Capital is a global VC fund headquartered in Portola Valley, California, United States investing in early stage, capital efficient technology companies in high-growth sectors. Almaz Capital focuses on disruptive deep tech companies in b2b software space, including AI/ML and Blockchain applications, IoT and Edge Computing Enablers, Cybersecurity, etc. Since its foundation the firm's portfolio has included about 50 companies, with more than 300 million US dollars invested in them.
H1 Inc. is a global healthcare data technology company founded in 2017, and headquartered in New York City. The company's database is used by healthcare and pharmaceutical companies and related organizations to identify healthcare professionals to partner with on research in order to accelerate development of drugs and other treatments. The company has over 400 employees worldwide and about 100 clients including pharmaceutical companies Novartis and AstraZeneca as of November 2021.
Owkin is an AI biotech company that uses artificial intelligence to identify new treatments, optimize clinical trials and develop AI diagnostics. The company uses federated learning, a type of privacy preserving technology, to access multimodal patient data from academic institutions and hospitals to train its AI models for drug discovery, development, and diagnostics. Owkin has collaborated with pharmaceutical companies around the world to improve their therapeutic programs.